| Nov 15 |
Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here's What You Should Know
|
| Nov 13 |
Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year?
|
| Nov 9 |
Adaptive Biotechnologies Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 8 |
Q3 2024 Adaptive Biotechnologies Corp Earnings Call
|
| Nov 8 |
Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ...
|
| Nov 8 |
Adaptive Biotechnologies Corporation (ADPT) Q3 2024 Earnings Call Transcript
|
| Nov 7 |
Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
| Nov 7 |
Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 7 |
Adaptive Biotechnologies: Q3 Earnings Snapshot
|
| Nov 7 |
Adaptive Biotechnologies GAAP EPS of -$0.22 beats by $0.07, revenue of $46.44M beats by $6.21M
|
